GSK-932121

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGSK-932121
Drug Alias NameGSK-932121GSK-932121A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitochondrial complex I (NADH dehydrogenase) inhibitors
TargetsMitochondrial complex I (NADH dehydrogenase)
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline PlcMedicines for Malaria Venture
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A